Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure

Conditions:   Heart Failure NYHA Class II;   Heart Failure NYHA Class III;   Heart Failure Intervention:   Sponsors:   University of Pennsylvania;   Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials